Juan Miguel Mosquera

European Bioinformatics Institute — United Kingdom

Medicine · Health Sciences

53h-index22.7kcitations455works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(200), Cancer Genomics and Diagnostics(113), Prostate Cancer Diagnosis and Treatment(46), Cancer Immunotherapy and Biomarkers(38), Radiopharmaceutical Chemistry and Applications(38)

Publications452 total

Passenger mutations link cellular origin and transcriptional identity in human lung adenocarcinomas
Nature Genetics·2025· 1 cited
Figure S1 from Immunogenomic Landscape of Neuroendocrine Prostate Cancer
2025Open Access
Figure S4 from Immunogenomic Landscape of Neuroendocrine Prostate Cancer
2025Open Access
Figure S5 from Immunogenomic Landscape of Neuroendocrine Prostate Cancer
2025Open Access
Figure S3 from Immunogenomic Landscape of Neuroendocrine Prostate Cancer
2025Open Access
Figure S2 from Immunogenomic Landscape of Neuroendocrine Prostate Cancer
2025Open Access
Supplementary Data Tables 1 from Immunogenomic Landscape of Neuroendocrine Prostate Cancer
2025Open Access
ChEBI: re-engineered for a sustainable future
Nucleic Acids Research·2025· 6 citedOpen Access
Paired plus-minus sequencing is an ultra-high throughput and accurate method for dual strand sequencing of DNA molecules
2025· 2 citedOpen Access
Integrative transcriptomic and single-cell protein characterization of colorectal carcinoma delineates distinct tumor immune microenvironments associated with overall survival
Pathology - Research and Practice·2025
SPINK1 immunohistochemistry: An ancillary tool to diagnose urothelial carcinoma in situ and urothelial dysplasia
Pathology - Research and Practice·2025
Comparison of Whole Genome Sequencing with Clinical Targeted Panel Sequencing of Metastatic Prostate Cancer: Insights from Real- World Data
2025Open Access
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancer
2025Open Access
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer
Nature Communications·2025· 4 citedOpen Access
Multidisciplinary management and genetic findings in an Ashkenazi Jewish male: case report of pathogenic BRCA2 and adenomatous polyposis coli mutations
Academia oncology.·2025Open Access
EXaCT-2: An augmented and customizable oncology-focused whole exome sequencing platform
2025Open Access
CLONEVO: Preoperative abemaciclib for cisplatin-ineligible muscle-invasive bladder cancer (MIBC) with molecular response assessment.
Journal of Clinical Oncology·2025· 4 cited
Abstract CT127: Pre-operative abemaciclib in localized cisplatin-ineligible MIBC with tissue and ctDNA molecular response validation (CLONEVO)
Cancer Research·2025
Author Correction: Unsupervised discovery of tissue architecture in multiplexed imaging
UNC Libraries·2025Open Access
Pan-Cancer PDOs Preserve Tumor Heterogeneity and Uncover Therapeutic Vulnerabilities
2025Open Access
page 1 of 23Next →

Frequent Co-authors

Mark A. Rubin(40), Himisha Beltran(30), Andrea Sboner(24), Olivier Elemento(22), Francesca Demichelis(20), David M. Nanus(17), Scott T. Tagawa(17), Brian D. Robinson(13), Theresa Y. MacDonald(13), Kyung Park(12), Davide Prandi(8), Loredana Puca(8), Rohan Bareja(8), Joanna Cyrta(7), Alessandro Romanel(7), Michael Sigouros(7), Eliezer M. Van Allen(6), Howard I. Scher(6), Levi A. Garraway(6), Ashutosh Tewari(6)